One study indicated that anti-prothrombin antibodies are related to hypertension through a comparison of a patient group with severe essential hypertension with a matched group of healthy controls; it revealed that 8% of the participants in a patient group had anti-prothrombin antibodies compared with none of the healthy controls [44]. The gene discussed is F2; the disease is essential hypertension.